Meeting
2023 ASCO Annual Meeting
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).
Authors
Kyle M Rose
H. Lee Moffitt Cancer Center, Tampa, FL
Kyle M Rose , Roger Li , Andrea Necchi , Facundo Davaro , Elizabeth Davaro , Philippe E. Spiess , Petros Grivas , Gennady Bratslavsky , Joseph M Jacob , Alina Basnet , Dean C. Pavlick , Richard S.P. Huang , Douglas I. Lin , Natalie Danziger , Julia C. F. Quintanilha , James Haberberger , Jeffrey S. Ross , Ryon Graf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Urothelial Cancer - Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4587)
DOI
10.1200/JCO.2023.41.16_suppl.4587
Abstract #
4587
Poster Bd #
79
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).
First Author: Andrea Necchi
Poster
2022 ASCO Genitourinary Cancers Symposium
Genomic classification of clinically advanced major genito-urinary cancers (GUca) based on methylthioadenosine phosphorylase (MTAP) genomic loss.
First Author: Philippe E. Spiess
Poster
2016 Genitourinary Cancers Symposium
Characterization of mutational load in patients with advanced urothelial cancer.
First Author: Sumanta K. Pal
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi